en
Feedback
Neurology Updates

Neurology Updates

Open in Telegram

All the atest articles, research and news from worlds leading Neurology Journals. Discussion group https://t.me/Professional_Medical_Discussion

Show more

šŸ“ˆ Analytical overview of Telegram channel Neurology Updates

Channel Neurology Updates (@neurology_updates) in the English language segment is an active participant. Currently, the community unites 16 175 subscribers, ranking 1 504 in the Medicine category and 2 332 in the USA region.

šŸ“Š Audience metrics and dynamics

Since its creation on невіГомо, the project has demonstrated rapid growth, gathering an audience of 16 175 subscribers.

According to the latest data from 05 September, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by 311 over the last 30 days and by 5 over the last 24 hours, overall reach remains high.

  • Verification status: Not verified
  • Engagement rate (ER): The average audience engagement rate is 6.93%. Within the first 24 hours after publication, content typically collects 2.64% reactions from the total number of subscribers.
  • Post reach: On average, each post receives 1 121 views. Within the first day, a publication typically gains 427 views.
  • Reactions and interaction: The audience actively supports content: the average number of reactions per post is 1.
  • Thematic interests: Content is focused on key topics such as disease, stroke, alzheimer, cell, dementia.

šŸ“ Description and content policy

The author describes the resource as a platform for expressing subjective opinions:
ā€œAll the atest articles, research and news from worlds leading Neurology Journals. Discussion group https://t.me/Professional_Medical_Discussionā€

Thanks to the high frequency of updates (latest data received on 06 September, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Medicine category.

16 175
Subscribers
+524 hours
+467 days
+31130 days
Attracting Subscribers
September '26
September '26
+34
in 0 channels
August '26
+363
in 0 channels
Get PRO
July '26
+419
in 0 channels
Get PRO
June '26
+379
in 0 channels
Get PRO
May '26
+451
in 0 channels
Get PRO
April '26
+353
in 0 channels
Get PRO
March '26
+133
in 0 channels
Get PRO
February '26
+165
in 0 channels
Get PRO
January '26
+212
in 0 channels
Get PRO
December '25
+188
in 0 channels
Get PRO
November '25
+233
in 2 channels
Get PRO
October '25
+263
in 0 channels
Get PRO
September '25
+270
in 0 channels
Get PRO
August '25
+434
in 0 channels
Get PRO
July '25
+435
in 0 channels
Get PRO
June '25
+288
in 0 channels
Get PRO
May '25
+295
in 0 channels
Get PRO
April '25
+351
in 0 channels
Get PRO
March '25
+358
in 0 channels
Get PRO
February '25
+368
in 0 channels
Get PRO
January '25
+629
in 2 channels
Get PRO
December '24
+636
in 0 channels
Get PRO
November '24
+857
in 0 channels
Get PRO
October '24
+902
in 0 channels
Get PRO
September '24
+922
in 0 channels
Get PRO
August '24
+696
in 0 channels
Get PRO
July '24
+506
in 2 channels
Get PRO
June '24
+500
in 0 channels
Get PRO
May '24
+552
in 1 channels
Get PRO
April '24
+485
in 0 channels
Get PRO
March '24
+495
in 0 channels
Get PRO
February '24
+649
in 0 channels
Get PRO
January '24
+889
in 0 channels
Get PRO
December '23
+816
in 1 channels
Get PRO
November '23
+33
in 0 channels
Get PRO
October '23
+51
in 0 channels
Get PRO
September '23
+28
in 0 channels
Get PRO
August '23
+43
in 0 channels
Get PRO
July '23
+58
in 0 channels
Get PRO
June '23
+40
in 0 channels
Get PRO
May '23
+32
in 0 channels
Get PRO
April '23
+39
in 0 channels
Get PRO
March '23
+52
in 0 channels
Get PRO
February '23
+29
in 0 channels
Get PRO
January '23
+28
in 0 channels
Get PRO
December '22
+28
in 0 channels
Get PRO
November '22
+64
in 0 channels
Get PRO
October '22
+25
in 0 channels
Get PRO
September '22
+65
in 0 channels
Get PRO
August '22
+31
in 0 channels
Get PRO
July '22
+22
in 0 channels
Get PRO
June '22
+42
in 0 channels
Get PRO
May '22
+40
in 0 channels
Get PRO
April '22
+23
in 0 channels
Get PRO
March '22
+21
in 0 channels
Get PRO
February '22
+11
in 0 channels
Get PRO
January '22
+22
in 0 channels
Get PRO
December '21
+23
in 0 channels
Get PRO
November '21
+15
in 0 channels
Get PRO
October '21
+28
in 0 channels
Get PRO
September '21
+21
in 0 channels
Get PRO
August '21
+26
in 0 channels
Get PRO
July '21
+30
in 0 channels
Get PRO
June '21
+65
in 0 channels
Get PRO
May '21
+34
in 0 channels
Get PRO
April '21
+144
in 0 channels
Get PRO
March '21
+109
in 0 channels
Get PRO
February '21
+27
in 0 channels
Get PRO
January '21
+26
in 0 channels
Get PRO
December '20
+428
in 0 channels
Date
Subscriber Growth
Mentions
Channels
05 September+9
04 September+13
03 September+7
02 September+5
01 September0
Channel Posts
Neuromodulation for restoring and amplifying brain function https://www.nature.com/articles/s41593-026-02434-6

2
Neural geometry guides learning https://www.nature.com/articles/s41593-026-02442-6
440
3
Structured experience shapes strategy learning and neural dynamics in the medial entorhinal cortex https://www.nature.com/articles/s41593-026-02409-7
598
4
Priming of CD8<sup>+</sup> T cells by peripheral dendritic cells exacerbates tau-mediated neurodegeneration https://www.nature.com/articles/s41593-026-02427-5
552
5
Mitochondrial calcium influx-driven bioenergetics selectively enable drug addiction https://www.nature.com/articles/s41593-026-02421-x
631
6
Glutamate concentration tunes AMPA receptor function through conductance-state occupancy https://www.nature.com/articles/s41593-026-02414-w
584
7
[Articles] Prevalence of unruptured intracranial aneurysms according to comorbidities, risk factors, country, and time period: a systematic review and meta-analysis https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(26)00276-0/fulltext?rss=yes
703
8
[Comment] Finding more intracranial aneurysms that will never rupture https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(26)00315-7/fulltext?rss=yes
666
9
Whole-exome sequencing in individuals with obsessive–compulsive disorder and chronic tic disorders identifies 36 large-effect risk genes https://www.nature.com/articles/s41593-026-02419-5
724
10
State-dependent signal flow hierarchy in the human cerebral cortex https://www.nature.com/articles/s41593-026-02389-8
674
11
ATTs in Patients With Non-AD Copathologies https://jamanetwork.com/journals/jamaneurology/fullarticle/2853597
739
12
Tirofiban for Branch Atheromatous Disease–Related Stroke https://jamanetwork.com/journals/jamaneurology/fullarticle/2853598
681
13
Treatment Discontinuation in MOGAD—One Size Does Not Fit All—Reply https://jamanetwork.com/journals/jamaneurology/fullarticle/2853599
610
14
Treatment Discontinuation in MOGAD—One Size Does Not Fit All https://jamanetwork.com/journals/jamaneurology/fullarticle/2853600
693
15
Tirofiban for Branch Atheromatous Disease https://jamanetwork.com/journals/jamaneurology/fullarticle/2853601
730
16
Spatial mapping of RNA turnover kinetics in the mouse brain https://www.nature.com/articles/s41593-026-02420-y
845
17
https://www.instagram.com/updates_in_medicine?igsi=eWJ2N3p2MmxvNXJ0&utm_source=qr
https://www.instagram.com/updates_in_medicine?igsi=eWJ2N3p2MmxvNXJ0&utm_source=qr
587
18
Social isolation recruits amygdala–medial prefrontal cortex projections to escalate alcohol drinking in male mice https://www.nature.com/articles/s41593-026-02413-x
1 524
19
[Articles] Safety, tolerability, and efficacy of alixorexton, a selective orexin 2 receptor agonist for narcolepsy type 1 (Vibrance-1): a randomised, double-blind, placebo-controlled, phase 2 trial https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(26)00278-4/fulltext?rss=yes
1 370
20
[Comment] Targeting orexin signalling in narcolepsy https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(26)00316-9/fulltext?rss=yes
1 127